CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Tickers
- INDV SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Securities
- INDV Common stock Nasdaq
- SUPN Common Stock Nasdaq
- 4 Grant or award Chief Financial Officer acquired 37,358 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 26,897 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 33,622 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 31,380 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 79,976 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 5,955 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 1,771 shares at $35.39 ($62,680)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 4 · 70 filings